Episode Synopsis "Myasthenia Gravis: Management"

Pyridostigmine, steroids, steroid-sparing immunosuppressants, thymectomies, and COVID-19 vaccines in patients with myasthenia gravis Dr. Michelle Kaku interviewed by Dr. Dave Ho

Listen "Myasthenia Gravis: Management"

More episodes of the podcast Neurology Clinical Pearls

• Announcement
• CNS Lymphoma
• Intracranial Aneurysm Management (Part 2 of 2)
• Intracranial Aneurysm Management (Part 1 of 2)
• Neurosarcoidosis (Part 2 of 2)
• Neurosarcoidosis (Part 1 of 2)
• Neurological Manifestations of Amyloidosis (Part 2 of 2)
• Neurological Manifestations of Amyloidosis (Part 1 of 2)
• Epilepsy in Women (Part 2 of 2)
• Epilepsy in Women (Part 1 of 2)
• Post-traumatic Brain Injury
• Autism Spectrum Disorders
• Neurocysticercosis
• Embolic Stroke of Undetermined Sourced (ESUS)
• Atypical Peripheral Neuropathy
• Typical Peripheral Neuropathy
• Diagnosis of ALS (Part 2 of 2)
• Diagnosis of ALS (Part 1 of 2)
• Parkinson's Disease and Parkinsonism (Part 2 of 2)
• Parkinson's Disease and Parkinsonism (Part 1 of 2)
• Myasthenia Gravis: Management
• Myasthenia Gravis: Diagnosis
• Approach to Tremor (Part 2 of 2)
• Approach to Tremor (Part 1 of 2)
• Approach to Low Back Pain
• Approach to Clinically Isolated Syndrome
• Updates on Migraine Management